Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Moderna, Inc.
Moderna, Inc.
MRNA
Valuace
100
Růst
30
Zdraví
75
Cena
$ 23.89
Dnes
+2.48 (6.29%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
9.3B
Obrat
2B
Zisk
-3B
Aktiva
12B
Dluh
1B
ROE
0%
ROA
0%
PE
-6
PS
8
Cena 1R
22-45
⌀ Cena
27.64
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
13-02-2026
Poslední dividenda

Profil

Moderna, Inc., biotechnologická společnost, objevuje, vyvíjí a komercializuje messenger RNA terapeutické a vakcíny pro léčbu infekčních onemocnění, imunonkologie, vzácných onemocnění, kardiovaskulárních onemocnění a autoimunitních onemocnění ve Spojených státech, Evropě a mezinárodně. Mezi jeho respirační vakcíny patří COVID-19, chřipka, respirační syncytiální virus, endemická vakcína proti HCoV a vakcína proti hMPV+PIV3; latentní vakcíny zahrnují vakcíny proti cytomegaloviru, epstein-barrovu viru, viru lidské imunodeficience, herpes simplex viru a viru varicella-zoster; vakcíny proti veřejnému zdraví se skládají z vakcín proti zice a Nipah. Společnost také nabízí systémovou sekretovanou a buněčnou povrchovou terapii; rakovinné vakcíny, jako jsou personalizované rakovinné, KRAS a checkpointové vakcíny; intratumorální imuno-onkologické přípravky; lokalizovanou regenerativní, systémovou intracelulární a inhalační plicní terapii. Má strategická spojenectví s AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; Defence Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; a The Bill & Melinda Gates Foundation, a také spolupráci a licenční smlouvu s Chiesi Farmaceutici S.P.A. Společnost byla dříve známá jako Moderna Therapeutics, Inc. a v srpnu 2018 změnila svůj název na Moderna, Inc. Moderna, Inc. byla založena v roce 2010 a má sídlo v Cambridge v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
5800
Založení
2018-12-07
Adresa
200 Technology Square
CEO
Stephane Bancel
Web
www.modernatx.com

Podobné společnosti

TECH
Bio-Techne Corporation
$ 57.36
- $ 0.05
BMRN
BioMarin Pharmaceutical Inc.
$ 52.17
+ $ 0.71
EXEL
Exelixis, Inc.
$ 40.25
- $ 0.56
MDGL
Madrigal Pharmaceuticals, Inc.
$ 487.29
- $ 1.97
RNA
Avidity Biosciences, Inc.
$ 69.78
- $ 0.06
RVMD
Revolution Medicines, Inc.
$ 62.37
+ $ 1.36
JAZZ
Jazz Pharmaceuticals plc
$ 132.79
+ $ 1.63

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016
Total Revenues1,943.01,944.03,199.06,848.019,263.017,736.0274.548.0122.5177.0101.5
Cost of Revenues1,669.0868.01,464.04,693.05,416.02,617.07.90.0-12.60.00.0
Gross Profit274.01,076.01,735.02,155.013,847.015,119.0266.648.0135.1177.0101.5
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues678.01,016.0142.0107.0956.01,855.0221.0167.02,813.01,831.0
Cost of Revenues452.01,008.0119.090.0739.0514.0115.096.0929.02,241.0
Gross Profit226.08.023.017.0217.01,341.0106.071.01,884.0-410.0
Operating Income TTM 2025202420232022202120202019201820172016
R&D Expenses0.00.00.04,845.03,295.01,991.01,370.3496.3454.1410.5274.7
Selling General & Admin Expenses0.00.00.01,549.01,132.0567.0188.3109.694.364.757.5
Depreciation & Amortization215.0215.0189.0621.0348.0232.031.331.024.920.515.1
Total Operating Expenses3,348.04,150.05,680.06,394.04,427.01,823.01,029.7593.8535.8446.3325.3
Operating Income-3,074.0-3,074.0-3,945.0-4,239.09,420.013,296.0-763.1-545.7-413.3-269.4-223.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.01,406.01,160.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0470.0442.0
Depreciation & Amortization67.052.057.039.060.052.041.036.0202.0249.0
Total Operating Expenses1,083.0268.0930.01,067.01,463.01,411.01,469.01,337.01,878.01,602.0
Operating Income-857.0-260.0-907.0-1,050.0-1,246.0-70.0-1,363.0-1,266.06.0-2,012.0
Net Income TTM 2025202420232022202120202019201820172016
Interest Income314.0314.0425.0421.0200.018.024.738.527.015.211.3
Interest Expense2.00.024.038.029.018.09.96.60.00.00.0
Other Expense306.0306.0338.0297.0155.0-11.018.631.01.8-1.9-2.7
IBT-2,768.0-2,768.0-3,607.0-3,942.09,575.013,285.0-744.5-514.7-384.4-256.0-215.2
Income Tax Expense54.054.0-46.0772.01,213.01,083.02.6-0.70.3-0.11.0
Net Income-2,822.0-2,822.0-3,561.0-4,714.08,362.012,202.0-747.1-514.0-384.7-255.9-216.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income70.073.081.090.091.0103.0111.0120.0103.0105.0
Interest Expense0.00.01.01.06.06.06.06.06.010.0
Other Expense58.073.089.086.062.091.084.0101.064.054.0
IBT-799.0-187.0-818.0-964.0-1,184.021.0-1,279.0-1,165.070.0-1,958.0
Income Tax Expense27.013.07.07.0-64.08.00.010.0-147.01,672.0
Net Income-826.0-200.0-825.0-971.0-1,120.013.0-1,279.0-1,175.0217.0-3,630.0
Per Share Data TTM 2025202420232022202120202019201820172016
EPS$0.00$0.00$0.00$-12.34$21.26$30.31$-1.96$-1.55$-4.74$-0.68$-0.58
EPS Diluted$0.00$0.00$0.00$-12.34$20.12$28.29$-1.96$-1.55$-4.74$-0.68$-0.58
Shares Outstanding392.0389.0384.0382.0394.0403.0381.0331.081.1376.0376.0
Diluted Shares Outstanding392.0389.0384.0382.0416.0431.0381.0331.081.1376.0376.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.57$-9.53
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.55$-9.53
Shares Outstanding392.0390.0388.0386.0385.0385.0384.0382.0381.0381.0
Diluted Shares Outstanding392.0390.0388.0386.0385.0399.0384.0382.0395.0381.0
Current Assets TTM 202420232022202120202019201820172016
Cash And Equivalents2,478.01,927.02,907.03,205.06,848.02,623.9235.9658.4134.950.1
Short Term Investments6,010.05,098.05,697.06,697.03,879.01,983.8867.1863.1621.21,008.1
Total Cash & ST Investments8,488.07,025.08,604.09,902.017,570.05,246.51,263.01,694.4756.01,058.1
Accounts Receivable423.0592.0892.01,385.03,296.01,410.516.330.616.718.0
Inventory399.0117.0202.0949.01,441.046.5-904.2-173.00.00.0
Other Current Assets351.0365.0643.01,195.055.0-405.6887.911.010.511.1
Total Current Assets9,661.08,099.010,325.013,431.017,570.06,297.91,263.01,563.0783.21,087.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents1,132.01,279.01,623.01,927.01,644.02,478.02,051.02,907.02,932.03,801.0
Short Term Investments3,372.03,852.04,352.05,098.05,223.06,010.06,472.05,697.04,641.04,658.0
Total Cash & ST Investments4,505.05,131.05,975.07,025.06,867.08,488.08,523.08,604.07,573.08,459.0
Accounts Receivable1,394.0457.0306.0592.01,836.0423.0387.0892.01,866.0232.0
Inventory332.0240.0128.0117.0412.0399.0295.0202.0487.0715.0
Other Current Assets367.0343.0357.0365.0551.0351.0395.0643.01,122.01,484.0
Total Current Assets6,598.06,171.06,766.08,099.09,666.09,661.09,600.010,325.010,799.010,599.0
Long-Term Assets TTM 202420232022202120202019201820172016
Net Property, Plant & Equipment2,971.02,955.02,658.02,139.01,383.0387.1287.9212.0139.081.2
Goodwill52.052.052.00.00.00.00.00.00.00.0
Intangible Assets42.040.044.00.00.00.00.00.00.00.0
Long-Term Investments2,359.02,508.04,743.08,318.06,843.0638.8160.0173.0145.9236.6
Other Long-Term Assets514.0407.0523.0988.046.012.9-121.514.216.412.2
Total Long-Term Assets6,019.06,043.08,101.012,427.07,099.01,038.9326.4399.1301.3330.0
Total Assets15,680.014,142.018,426.025,858.024,669.07,336.81,589.41,962.11,084.51,417.2
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment2,864.02,919.02,964.02,955.03,165.02,971.02,760.02,658.02,717.02,410.0
Goodwill52.052.052.052.052.052.052.052.052.052.0
Intangible Assets47.048.049.040.041.042.043.044.045.046.0
Long-Term Investments2,252.02,380.02,424.02,508.02,358.02,357.03,691.04,743.05,359.06,224.0
Other Long-Term Assets241.0359.0368.0407.0440.0516.0502.0523.0478.01,073.0
Total Long-Term Assets5,537.05,839.05,938.06,043.06,137.06,019.07,129.08,101.08,651.011,285.0
Total Assets12,135.012,010.012,704.014,142.015,803.015,680.016,729.018,426.019,450.021,884.0
Current Liabilities TTM 202420232022202120202019201820172016
Accounts Payable279.0405.0520.0487.0302.018.47.131.220.728.2
Short-Term Debt25.037.025.0196.0211.0469.667.779.172.725.1
Other Current Liabilities1,357.01,608.01,839.02,202.02,362.033.75.13.51.31.9
Current Liabilities2,363.02,206.03,015.04,923.09,128.04,388.8143.1222.8191.5162.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable267.0175.0226.0405.0373.0279.0183.0520.0494.0310.0
Short-Term Debt48.043.043.037.051.025.025.088.0239.0268.0
Other Current Liabilities1,203.01,136.01,210.01,608.01,394.01,350.01,561.01,839.02,280.01,505.0
Current Liabilities1,681.01,572.01,604.02,206.02,201.02,363.02,380.03,015.04,385.03,123.0
Long-Term Liabilities TTM 202420232022202120202019201820172016
Long-Term Debt1,244.0710.01,218.01,004.0705.0207.3132.433.515.712.5
Capital Leases1,244.0747.01,243.01,004.0916.0207.3132.433.515.712.5
Def. Tax Liability0.00.00.00.00.00.00.010.07.64.7
Total Liabilities3,968.03,241.04,572.06,735.010,524.04,775.4414.6431.9459.2575.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt686.0698.0702.0710.01,304.01,244.01,212.01,218.01,272.0947.0
Capital Leases0.0741.0745.0747.01,304.01,244.01,237.01,243.01,272.0947.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities2,805.02,611.02,638.03,241.03,876.03,968.03,912.04,572.05,995.04,935.0
Total Common Equity TTM 202420232022202120202019201820172016
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings11,152.010,045.013,606.018,320.09,958.0-2,243.5-1,496.5-1,006.6-621.9-365.7
Comprehensive Income-71.0-10.0-123.0-370.0-24.03.01.8-1.3-1.2-0.4
Total Common Equity11,712.010,901.013,854.019,123.014,145.02,561.41,174.81,530.2625.3841.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings8,049.08,249.09,074.010,045.011,165.011,152.012,431.013,606.013,389.017,019.0
Comprehensive Income27.023.010.0-10.011.0-71.0-101.0-123.0-211.0-263.0
Total Common Equity9,330.09,399.010,066.010,901.011,927.011,712.012,817.013,854.013,455.016,949.0
Other TTM 202420232022202120202019201820172016
Total Debt1,269.0747.01,243.01,200.0916.0207.3132.433.515.712.5
Book Value11,712.010,901.013,854.019,123.014,145.02,561.41,174.81,530.2625.3841.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value9,330.09,399.010,066.010,901.011,927.011,712.012,817.013,854.013,455.016,949.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016
Net Income-5,867.0-2,822.0-3,561.0-4,714.08,362.012,202.0-747.1-514.0-384.7-255.9-216.2
Depreciation & Amortization528.0215.0189.0621.0348.0232.031.331.024.920.515.1
Stock-Based Compensation369.0483.0429.0305.0226.0142.093.081.172.640.139.4
Change Working Capital345.0254.0-78.0-139.0-3,455.0990.02,577.1-53.7-42.6-137.2226.0
Change In Accounts Receivable69.0156.0534.0493.01,790.0-1,784.0-1,385.27.20.80.152.3
Change In Accounts Payable1.0-92.0-69.013.0240.0204.011.9-24.015.0-12.86.0
Change In Inventories316.0-34.083.0747.0492.0-1,394.0-46.57.24.434.8-0.6
Other Non-cash Items60.0-3.017.0-19.059.0372.062.3-3.4-1.01.12.5
Cash from Operations-3,241.00.00.0-3,118.04,981.013,620.02,027.0-459.0-330.9-331.566.7
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-826.0-200.0-825.0-971.0-1,120.013.0-1,279.0-1,175.0217.0-3,630.0
Depreciation & Amortization0.00.057.039.060.052.041.036.0202.0249.0
Stock-Based Compensation0.00.0130.0115.0104.0112.0112.0101.079.077.0
Change Working Capital1,580.0-818.0-297.0-211.01,737.086.0-146.060.0249.0182.0
Change In Accounts Receivable859.0-1,013.030.0280.01,206.0-1,401.0-26.0755.0974.0-1,634.0
Change In Accounts Payable22.089.0-47.0-156.034.096.0104.0-303.021.0179.0
Change In Inventories179.0-91.0-114.0-8.0291.0-11.0-104.0-93.0285.0228.0
Other Non-cash Items197.0171.016.0-9.044.0-1,829.0-2.0-11.0-158.058.0
Cash from Operations0.00.00.00.00.00.00.00.0622.0-1,600.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016
Capital Expenditure-738.0-192.0-1,051.0-707.0-400.0-284.0-67.4-31.6-105.8-58.4-33.1
Acquisitions2,178.00.00.0-85.00.00.00.00.00.00.00.0
Investments-5,846.0-5,768.0-6,529.0-3,760.0-11,435.0-12,652.0-2,956.3-1,145.2-1,227.7-727.2-1,415.5
Sales of Investment8,625.07,916.09,529.08,781.06,699.04,443.01,351.81,161.8960.41,203.0808.9
Other Investing Activities3,051.00.00.0-23.0-40.0-30.00.00.00.6-1.3-8.9
Cash from Investing2,018.00.00.04,206.0-5,176.0-8,523.0-1,671.9-14.9-372.5416.1-648.6
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-39.0-33.0-3.0-117.0-522.0-151.0-182.0-196.0-220.0-140.0
Acquisitions0.00.00.00.00.00.00.00.03,107.0-929.0
Investments-1,547.0-1,162.0-1,295.0-1,764.0-1,888.0-1,251.0-846.0-2,544.0-1,640.0-816.0
Sales of Investment1,538.01,895.01,862.02,621.01,871.02,123.02,677.02,858.01,345.01,745.0
Other Investing Activities0.00.00.00.00.00.00.00.01,345.00.0
Cash from Investing0.00.00.00.00.00.00.00.0-538.0789.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016
Debt Repaid-192.00.00.0-270.00.0-140.0-6.20.0-2.20.00.0
Debt Issued514.0747.0-496.0313.0284.0848.781.198.920.03.212.5
Issuance of Common Stock68.00.00.046.065.0124.01,852.747.3563.00.00.0
Repurchase of Common Stock1.00.00.0-1,153.0-3,329.0-857.07.02.9-8.20.00.0
Dividends Paid0.00.00.00.00.0-124.0-7.00.00.00.00.0
Other Financing Activities123.00.00.00.0-184.0124.0186.71.0674.20.2472.9
Cash from Financing-119.00.00.0-1,377.0-3,448.0-873.02,033.251.11,226.80.2472.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-124.0-65.0
Debt Issued734.0-7.0-4.0-2.0-608.086.032.01,237.0124.065.0
Issuance of Common Stock0.00.00.00.00.00.00.00.015.06.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.01.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.015.06.0
Cash from Financing0.00.00.00.00.00.00.00.0-109.0-58.0
Cash position TTM 2025202420232022202120202019201820172016
Net Change in Cash-1,340.0668.0-999.0-289.0-3,643.04,224.02,388.2-422.8523.584.8-109.0
Closing Cash Balance2,478.02,597.01,929.02,928.03,217.06,860.02,635.9247.7658.4134.950.1
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash1,462.0-147.0-345.0-303.0282.0-833.0409.0-857.0-25.0-869.0
Closing Cash Balance2,595.01,132.01,281.01,626.01,929.01,647.02,480.02,071.02,928.02,953.0
Free Cash Flow TTM 2025202420232022202120202019201820172016
Free Cash Flow-3,979.0-2,065.0-4,055.0-3,825.04,581.013,336.01,959.5-490.5-436.6-389.933.6
Real Free Cash Flow-4,348.0-2,548.0-4,484.0-4,130.04,355.013,194.01,866.5-571.6-509.2-429.9-5.8
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow912.0-880.0-922.0-1,164.0303.0-1,717.0-1,456.0-1,185.0402.0-1,740.0
Real Free Cash Flow912.0-880.0-1,052.0-1,279.0199.0-1,829.0-1,568.0-1,286.0323.0-1,817.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-5.6-3.3-1.4
P/S8.192.89.4
P/B1.76.65.2
P/FCF-6.83.7-1.5
Market cap$9.3$26.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %3.9 %0 %
Debt to Income-26 %-7.9 %0 %
Debt to Free cash flow-31.9 %-53 %0 %
Interest expense percentage-0.1 %-0.4 %44.7 %
Current ratio3.9 4.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-30.2 %-2.6 %0 %
ROA-23.3 %-4.1 %0 %
CapEx to Revenue9.9 %28.9 %0 %
RaD to Revenue0 %271.3 %0 %
ROEM335,000.0 1358570.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin14.1 %74.3 %68.7 %
Operating margin-158.2 %-239.7 %35.5 %
Net margin-145.2 %-227.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.1 %0 %
Dividend payout percentage0 %-1.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding392.0 mil 383.2 mil
Employee count5.8 tis 3.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader